Press Releases

• Number of shares and votes in Active Biotech
  Dec 30, 2024 08:30 (CET) Regulatory
• Active Biotech’s nomination committee appointed
  Dec 18, 2024 08:30 (CET) Regulatory
• Positive preclinical tasquinimod data in myelofibrosis presented at ASH 2024 now available on Active Biotech’s website
  Dec 9, 2024 08:30 (CET)
• Active Biotech raises SEK 43.4 million in substantially oversubscribed rights issue including exercise of over-allotment option
  Nov 18, 2024 23:30 (CET) Regulatory
• Active Biotech’s patent for laquinimod in eye disorders will be granted in the US
  Nov 13, 2024 08:30 (CET)